Order Lifepharm Global Products

Two Cholesterol Drugs May Work Better Together Than Apart

Two Cholesterol Drugs May Work Better Together Than Apart

The Effects of Stress on Your Body and Mind Are Staggering! Watch The Video Below To See What You Can Do To Regain Your Health...

Discover How Laminine™ Can Improve Your Health... Watch The Video Above!

Laminine™ Will Help Anyone. The Benefits, When Taken Regularly May Include...

  • Moderate the Stress Response
  • Maintain Healthy Cortisol Levels
  • Regulate Serotonin Levels
  • Reduce Physical and Mental Stress
  • Help Your Body Recover from Major Illnesses (e.g. Depression, Anxiety, Cancer)
  • Promote More Restful Sleep
  • Build Collagen for Healthier Skin
  • Reduce Signs of Normal Aging
  • Improve Emotional Balance
  • Promote Faster Post Workout Recovery
And Many More Health Benefits Reported By Everyday Users!




  • Enhance Muscle Tone and Strength
  • Improve Stamina and Energy
  • Increase Alertness
  • Aid in Brain Function and Activity (For people suffering from Alzheimer's syndrome, ADD, etc.)
  • Increase Physical and Mental Strength
  • Improve Focus
  • Increase Libido/Sexual Desire
  • Stimulate Natural DHEA Production
  • Improve the Overall Sense of Well-Being

Make 2017... the Year You Improve Your Health!

Join Thousands in 42 Countries (shown at the bottom of this page) Who Are Already Seeing Amazing Health Benefits from Regular Use of Laminine™ & Laminine™ Omega Plus!

"The Happy Pill"

Laminine™ is a Natural, Synergistic SuperFood that contains 22 amino acids, trace minerals, vitamins and Fibroblast Growth Factor (FGF) The perfect combination of life-giving sustenance sourced from land, sea and plant. Its source is from the "Miracle of Life". 

 Clinical Studies have been conducted which showed Laminine's™ positive effects on Physical, Mental, Emotional Strengths and Overall Health. Laminine™ is an all Natural Product
CLICK HERE To Join My Group & Order (Wholesale) & Choose the "Laminine™ Activation Pack"

In a new study of a class of cholesterol lowering drugs called PCSK9 inhibitors—which received much fanfare recently for lowering cholesterol to unprecedented levels —doctors wanted to know how they would work if taken along with statins, the gold standard for treating high LDL cholesterol. Do the drugs, which both work on cholesterol receptors in the liver but in slightly different ways, combine forces to lower LDL even further than either alone? Or do they negate each other’s effects, only producing as much reduction as either one alone?

Dr. Steven Nissen, chair of cardiovascular medicine at Cleveland Clinic, and his colleagues report the answer to those questions in a report in JAMA and in a presentation at the American Heart Association annual meeting. Among nearly 1,000 people with heart disease in six countries, they found that the combined effect of the PCSK9 inhibitor evolocumab and a statin lowered LDL dramatically — more than either drug alone. And that reduction came with a possible heart benefit — the drug combination also shrunk plaques that had been building up in the heart vessel walls of these people.

“The question was, could we do better than giving a statin alone, by giving the combination,” says Nissen. “And at the end of 18 months, we found [among the people taking the combination], there was less plaque than what the patients started with.”

All of the people in the study had at least one partially blocked major heart vessel, as well as other heart disease risk factors including a previous heart attack, unstable angina, type 2 diabetes, hypertension or were smokers. All were being treated with a statin to lower their cholesterol. For 18 months, they continued with their statin but about half were randomly assigned to receive evolobumab, a PCSK9 inhibitor, while the remaining people took a placebo. All also had ultrasound images taken of their heart at the start of the study and again toward the end to measure if and how much their plaque changed.

About 64% of people taking the combination of cholesterol-lowering drugs had their heart plaques shrink during the study, compared to 47% of those taking placebo. That suggests that the two-drug regimen might reverse atherosclerosis and potentially even avert some heart events by dissolving the fatty buildup that causes them.

“This study shows that for people with difficult-to-control cholesterol, we are beginning to accumulate evidence that there are drug options for them to not only lower cholesterol but to improve the health of their arteries,” says Nissen. “That’s new information.”

The study didn’t answer whether the cleaner vessels can actually lead to fewer heart attacks or heart deaths, but that would be the logical result. PCSK9 inhibitors like evolocumab were discovered after researchers found that some people had mutations in the PCSK9 gene and enjoyed astonishingly low LDL levels, around 20mg/dL (doctors recommend average adults aim for levels around 100mg/dL). Those people didn’t seem to have any health issues because of their mutation, but enjoyed lower than average risk of heart disease.

So the results raise the more complicated question of how low LDL levels should go, and whether current guidelines are set too high. Would more lives be saved, and more heart attacks averted, if LDL targets were set lower? The findings make a strong case that may be the case. The study found that for people with the lowest levels of LDL, the benefit from the paired drugs in reducing plaque in the arteries nearly doubled, suggesting that not only people with advanced disease but even those with lower amounts of plaque might benefit.

But for now, the combination isn’t accessible enough to be used widely. The study only looked at people with a history of heart problems; it says nothing yet about whether the combination of medications could be used to prevent first heart attacks in high risk people. Evolocumab isn’t a pill but has to be injected, and it’s expensive, costing about $1200 per month. So as effective as it may be, either alone or in combination with a statin, it’s likely out of reach for most people who might benefit.

Still, doctors now have another option for treating people who may have stubbornly high cholesterol levels that don’t drop with statins, diet and exercise alone. And reason to take a closer look at how low LDL should be set. “The science here is what is really interesting,” says Nissen, noting that the low levels of LDL achieved in the study by combining the drugs are found in nature among wild animals with low heart disease rates. “There seems to be a really big benefit to going really low.” The results of next year’s studies on how people on PCSK9 inhibitors fared on heart events will provide more evidence on whether that’s true.

After Clicking on One of the Links Below, Just CLICK the "Click Here to Agree and Continue" Button in the "Informed Consent and Participation Agreement" Form... to Begin Your Own Personal Q & A Session on How Laminine and Laminine Omega +++ Can Help You Achieve PERFECT Health.

Updated: November 15, 2016 — 7:30 pm

Copyright © 2019 - All Rights Reserved - Site Map - Resources (Add Your Link)

The statements and products referred to throughout this site have not been evaluated by the FDA. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult a physician.

Glenn Freiboth - (815) 524-3752 - CST - Glenn@perfecthealthpill.com - Company Site
An Independent Lifepharm® Distributor

Available In The Countries Below: 

Australia, Austria, Belgium, Bosnia-Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Indonesia, Ireland, Italy, Jamaica, Japan, Kazakhstan, Latvia, Lithuania, Luxembourg, Macedonia, Malaysia, Malta, Netherlands, New Zealand, Philippines, Poland, Portugal, Romania, Russian Federation, Serbia, Slovak Republic, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Ukraine, United Kingdom, United States - More Countries Coming Soon!